Cheng D, Yang S, Zhao X, & Wang G. (2022). The Role of Glucagon-Like Peptide-1 Receptor Agonists (GLP-1 RA) in Diabetes-Related Neurodegenerative Diseases. Dove Medical Press.
Chicago Style (17th ed.) CitationCheng D, Yang S, Zhao X, and Wang G. The Role of Glucagon-Like Peptide-1 Receptor Agonists (GLP-1 RA) in Diabetes-Related Neurodegenerative Diseases. Dove Medical Press, 2022.
MLA (9th ed.) CitationCheng D, et al. The Role of Glucagon-Like Peptide-1 Receptor Agonists (GLP-1 RA) in Diabetes-Related Neurodegenerative Diseases. Dove Medical Press, 2022.
Warning: These citations may not always be 100% accurate.